A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- Conditions
- OncologyMyeloid Leukemia, AcuteCancer
- Registration Number
- NCT06697600
- Lead Sponsor
- University of Rochester
- Brief Summary
This is a multicenter randomized controlled trial that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control.
- Detailed Description
This is a multicenter randomized controlled trial with four sites that assesses the efficacy of a decisional intervention \[University of Rochester-Geriatric Oncology assessment for Acute myeloid Leukemia (UR-GOAL)\] compared to an attention control. Subjects will be randomized 1:1 to either the intervention arm or the attention control arm. Compared to an attention control, UR-GOAL will improve patient distress, observed and patient-perceived shared decision making (SDM), and patient decisional conflict.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 640
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Distress Thermometer Questionnaire at 1 month 1 month A self-report measure to capture distress and identify a list of sources of that distress. This is a 10-item scale, rated from 0-10 (0=no distress, 10=severe distress), with a possible total of 10; a higher score indicates greater distress.
- Secondary Outcome Measures
Name Time Method 9-item Shared Decision Making Questionnaire at 2 weeks 2 weeks 9-item Shared Decision Making Questionnaire at 2 weeks
Decisional Conflict Scale Questionnaire at 2 weeks 2 weeks Decisional Conflict Scale Questionnaire at 2 weeks
Observed shared decision making Day 0 OPTION5 instrument from audio-recorded treatment decision-making clinical visits
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (3)
University of Alabama at Birmingham, Division of Hematology and Oncology
🇺🇸Birmingham, Alabama, United States
University of North Carolina Lineberger Comprehensive Cancer Center
🇺🇸Chapel Hill, North Carolina, United States
Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Section of Hematology/Oncology
🇺🇸Winston-Salem, North Carolina, United States